Matthew Beck

Matthew Beck

Plus aucun poste en cours

Finance
Health Technology
Commercial Services

Profil

Matthew Beck worked as an Executive Director-Investor Relations at HOOKIPA Pharma, Inc. from 2019 to 2023.
He also held the position of Vice President-Investor Relations at CureVac SE.
Prior to that, he was a Principal at Dunbar Capital Management LLC, Goldman Sachs & Co. LLC, Thomcorp Holdings, Inc., and Carson Group, Inc. (New York).
In 2018, he briefly served as a Senior Vice President at The Trout Group LLC.
He also worked as a Principal at NASDAQ.
In 2023, he will be a Vice President-Investor Relations & Communications at Actinium Pharmaceuticals, Inc. Mr. Beck completed his undergraduate degree at Vassar College.

Anciens postes connus de Matthew Beck

SociétésPosteFin
ACTINIUM PHARMACEUTICALS, INC. Investor Relations Contact 01/09/2023
HOOKIPA PHARMA INC. Investor Relations Contact 01/04/2023
Corporate Officer/Principal 03/01/2018
Public Communications Contact -
Corporate Officer/Principal -
Voir l'expérience en détail de Matthew Beck

Formation de Matthew Beck

Vassar College Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Matthew Beck

Relations

16

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
ACTINIUM PHARMACEUTICALS, INC.

Health Technology

HOOKIPA PHARMA INC.

Health Technology

Entreprise privées7

Health Technology

Finance

Finance

Commercial Services

Finance

Finance

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Matthew Beck